"Designing Growth Strategies is in our DNA"

U.S. Brain Tumor Drugs Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy, and Others), By Indication (Pituitary, Meningioma, Glioma, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: December 08, 2025 | Format: PDF | Report ID: FBI108123

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Brain Cancer
    2. Key Industry Developemnts: Mergers, Acquisitions, and Partnerships
    3. Overview of Regulatory Scenario
    4. New Product Launches by Key Players
    5. Impact of COVID-19 on the Market
  5. U.S. Brain Tumor Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary
      2. Meningioma
      3. Glioma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Merck & Co. Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Amneal Pharmaceuticals LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Amgen Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. NextSource Pharmaceuticals, LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
    3. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Brain Cancer
    2. Key Industry Developemnts: Mergers, Acquisitions, and Partnerships
    3. Overview of Regulatory Scenario
    4. New Product Launches by Key Players
    5. Impact of COVID-19 on the Market
  5. U.S. Brain Tumor Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary
      2. Meningioma
      3. Glioma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Merck & Co. Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Amneal Pharmaceuticals LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Amgen Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. NextSource Pharmaceuticals, LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
    3. Other Prominent Players
Read Less

Figure 1: U.S. Brain Tumor Drugs Market Revenue Breakdown (USD Million, %), By Indication, 2022 & 2030

Figure 2: U.S. Brain Tumor Drugs Market Value Share (%), by Therapy, 2022 & 2030

Figure 3: U.S. Brain Tumor Drugs Market Value Share (%), by Indication, 2022 & 2030

Figure 4: U.S. Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 5: U.S. Brain Tumor Drugs Market Share (%), By Company, 2022

Table 1: U.S. Brain Tumor Drugs Market Revenue (USD Million) Forecast, by Therapy, 2019–2030

Table 2: U.S. Brain Tumor Drugs Market Revenue (USD Million) Forecast, by Indication, 2019–2030

Table 3: U.S. Brain Tumor Drugs Market Revenue (USD Million) Forecast, by Distribution Channel, 2019–2030

U.S. Brain Tumor Drugs Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports